4//SEC Filing
Holtz Ron 4
Accession 0001209191-21-064878
CIK 0001287098other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:09 PM ET
Size
20.5 KB
Accession
0001209191-21-064878
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Holtz Ron
SVP and CAO
Transactions
- Exercise/Conversion
Common Stock
2021-11-12$0.04/sh+21,485$859→ 171,736 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-12−21,485→ 233,807 totalExercise: $0.04Exp: 2024-11-11→ Common Stock (21,485 underlying) - Exercise/Conversion
Common Stock
2021-11-15$0.04/sh+64,385$2,575→ 189,636 total - Sale
Common Stock
2021-11-15$12.16/sh−64,385$782,922→ 125,251 total - Sale
Common Stock
2021-11-12$12.65/sh−46,485$588,035→ 125,251 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-16−39,130→ 130,292 totalExercise: $0.04Exp: 2024-11-11→ Common Stock (39,130 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-15−64,385→ 169,422 totalExercise: $0.04Exp: 2024-11-11→ Common Stock (64,385 underlying) - Exercise/Conversion
Common Stock
2021-11-16$0.04/sh+39,130$1,565→ 164,381 total - Sale
Common Stock
2021-11-16$12.08/sh−39,130$472,690→ 125,251 total
Footnotes (4)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]This option is fully vested and exercisable.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001874490
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 7:09 PM ET
- Size
- 20.5 KB